Insecticides India Ltd

Q3 FY26Fertilizers & Agrochemicals

Insecticides India Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹610

Market cap₹1.8K Cr

P/E14.7

Updated23 Aug 2026

Read4 min read

The short version

The company targets a sustainable growth of 8% to 10% over the next 2 to 3 years. Company targets **low double-digit EBITDA margins** for the full year, with a cautious improvement expected beyond that (Pages 16-17).

From Insecticides India Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

The company targets a sustainable growth of 8% to 10% over the next 2 to 3 years.
Growth for FY '27 is expected to be cautiously positive, with recovery signs starting in Q1.
At least 5 new product launches are planned in Q1 of FY '27, including specialty and proprietary products.
The focus is on premiumization and specialty products, which command higher farmer investment and improve margins.
Volume-led growth is anticipated, with B2B segment growing approximately 15% and B2C segment around 3-4%.
The company expects improved profitability with better product mix, operational efficiency, and working capital management.
Exports are gaining traction with 180+ registrations across 22 countries, supporting long-term revenue growth.
Overall, the company is focusing on quality growth, portfolio expansion, and strategic global collaborations to drive future sales.

Profitability & Margins

Company targets **low double-digit EBITDA margins** for the full year, with a cautious improvement expected beyond that (Pages 16-17).
EBITDA might be flat short-term but expected to increase through rationalizing non-essential capex and working capital efficiency (Page 17).
Focus on **premium and specialty products** to drive better margins and profitability growth (Pages 12-13, 17).
Sales growth forecasted at around **8%-10% over the next 2-3 years**, reflecting a clear growth revival roadmap (Page 6).
Margins expected to be better than top-line growth but Q4 may see muted profitability due to seasonality and market conditions (Page 15).
FY 2027 expected to be a **good year cautiously** with signs of recovery starting Q1 (Page 15).
Company emphasizes **discipline and long-term franchise strength** over short-term margin optics (Page 6).
Continuous focus on building **Maharatna and Focus Maharatna category products** expected to be revenue and profit engines (Page 17).

See what Insecticides India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

New formulation and technical plant at Dahej site is operational and expected to improve performance in FY '27.
Sotanala facility: formulation plant to start Q1 of FY '27, technical plant expected in 2027.
Capex focused on capacity creation and maintenance aligned with medium-term growth priorities.
Backward integration planned selectively for specialist products to gain cost advantage and improve profitability.
Investment decisions based on ROCE and ROE; non-essential capex being frozen to rationalize business.
Strategy includes expanding technical capacity selectively; building new technical plants typically takes around 2-3 years.
Plans to double investment in ICS Plots (Integrated Crop Solutions) to deepen farmer connect and brand equity.
Emphasis on disciplined capital allocation with focus on increasing capital efficiency and improving organizational revenue, ROCE, and ROE by 6-7% over three years.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company has utilized about INR 200 crores of bank finance this year, resulting in some visible finance costs.
This debt has already been reduced to approximately INR 150 crores, with expectations to minimize it further by the end of the current quarter.
The company has been essentially a zero-debt company for the last 2 years prior to this utilization.
There is no explicit mention of plans for new fundraising through either debt or equity in the provided excerpts.
The company is focusing on cautious capital allocation, prioritizing capacity creation and maintenance aligned with medium-term growth priorities.
Overall, there is no indication of any immediate or planned new fundraising through debt or equity at present.

See what Insecticides India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention specific details about current or expected orderbook/pending orders. However, some related points include: - Focus on selective sales in Q4 with faster conversion on identified geographies, crops, and accounts to protect top line and market share. - Emphasis on strict pricing floors and order-wise profitability tracking in B2B sales. - Continued traction from new product launches contributing to order flow and demand. - International business is gradually gaining traction with registrations underway in markets like Latin America and Australia. - The company aims to build momentum in specialty and premium products, suggesting a positive outlook on incoming orders. - Tight controls on inventory and working capital hint at active order management and fulfillment focus. No explicit quantitative orderbook or pending orders were disclosed in the call.

Insecticides India Ltd — Quarterly revenue & net profit

Revenue Net profit

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹385 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Insecticides India Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsciences Ltd (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…
Rallis India Ltd (Q3 FY26)
Domestic B2C business growing steadily with 13% growth in Q3; volume expansion despite some price softness. Key concall takeaways from Rallis India's Q3 FY26…
Sharda Cropchem Ltd (Q3 FY26)
Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…
Krishana Phoschem Ltd (Q3 FY26)
It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Key concall takeaways from Krishana…

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Insecticides India Ltd Q3 FY26 results?

What is Insecticides India Ltd share price analysis?

Insecticides India Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,837 Cr. Investors should review the full earnings analysis for detailed insights.

Is Insecticides India Ltd planning capital expenditure?

New formulation and technical plant at Dahej site is operational and expected to improve performance in FY '27.

Keep Insecticides India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.